Oralair

Allergen Extract From Dactylis Glomerata, Anthoxanthum Odoratum, Lolium Perenne, Poa Prate, the active ingredient in Oralair, is a allergen immunotherapy presented as a tablet for sublingual use. It treats grass‑pollen‑induced allergic rhinitis and related symptoms in children and adults. GNH USA supplies Oralair as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oralair is used in allergen immunotherapy for grass‑pollen‑induced allergic rhinitis and related conditions. - Seasonal allergic rhinitis (hay fever): reduces nasal congestion, sneezing and itching during grass pollen season. - Allergic conjunctivitis: alleviates eye itching, redness and tearing caused by grass pollen exposure. - Grass‑pollen‑triggered bronchial asthma: may improve asthma control in sensitised patients.

Common Side Effects: - Mouth itching: mild irritation of the oral mucosa. - Throat irritation: transient soreness after tablet placement. - Ear pruritus: occasional itching in the ear canal. - Mild oral swelling: slight enlargement of lips or tongue that resolves quickly.

Serious or Rare Side Effects: - Anaphylaxis: severe, potentially life‑threatening allergic reaction. - Systemic allergic reaction: widespread hives, wheezing or hypotension. - Swelling of the tongue or throat: may compromise airway. - Persistent wheezing: ongoing respiratory difficulty requiring medical attention.

Oralair should be administered under medical supervision with attention to the following precautions. - Medical supervision: initiate treatment under the guidance of an allergist or qualified physician. - Age restrictions: approved for patients aged 5 years and older. - Concurrent immunotherapy: avoid using other allergen immunotherapy products simultaneously. - Pregnancy and lactation: discuss potential risks with a healthcare provider before use. - Store at ambient temperature below 25°C: keep in the original container, protect from moisture and light.

Oralair may interact with other medications; consider the following. Major Interactions (Avoid): - Beta‑blockers: can mask symptoms of anaphylaxis and complicate emergency treatment. - ACE inhibitors: may increase the risk of severe allergic reactions. Moderate Interactions (Monitor Closely): - Antihistamines: may reduce local side effects but do not affect efficacy. - Corticosteroids: could alter the immune response to the immunotherapy. - Other sublingual immunotherapy products: risk of additive allergic reactions.